Abstract:4740 Currently approved photo-dynamic therapy (PDT) agents are limited by their activation wavelengths which fall short of the tissue transparency window (700-1000 nm). With these agents, it is only feasible to treat tumors up 2-3 mm below the skin, or the activating light sources must be introduced into the tissue of interest. Other limitations are poor selectivity for tumor tissue and long residence times leading to extended light sensitivity. We have designed novel modular PDT agents that can be activated in the tissue transparency window, are targeted to the tumor tissue, and possess a module (indodicarbocyanine) for near infrared fluorescence (IR) imaging. Two-photon excited fluorescence has been demonstrated for these compounds at depths of 3 cm in highly scattering tissue phantoms. A protocol for evaluating the ability of PDT to kill tumor cells at specific depths in a tissue phantom was developed and the model was validated using Photofrin® treated MDA-MB-231 cells. Using in vivo near IR fluorescence imaging of SCID mice bearing MDA-MB-231 human breast cancer tumors, we validated the ability of the compounds to be targeted by the octreoate peptide to overexpressed somatostatin 2 (SST2) receptors on the cancer cells. Drug clearance was imaged occurring via the gall bladder and intestinal route, and the in vivo imaging studies indicated that there would likely be a good window of time for therapeutic activation of the compound. Since our compounds are the first ones to have a 2-photon cross section large enough to be considered for therapeutic PDT, appropriate protocols needed to be developed for many of the preclinical studies, and, while we envision any clinical application encompassing the ability to raster the near IR laser beam(s), until such a system is developed, we have adapted a motorized X,Y,Z stage to raster the target cells/tumor bearing mouse. Our initial results using this system will be presented. Supported by a grant from the Montana Board of Research and Commercialization and Technology.

Study of cytotoxic effect of photodynamically and sonodynamically activated sensitizers in vitro

The in-vitro proliferation-suppression of MCF-7 and HeLa cell lines mediated by differently substituted ionic phthalocyanines in sonodynamic therapy supplemented-photodynamic therapy

Cellular Imaging and Time-Domain FLIM Studies of Meso-Tetraphenylporphine Disulfonate as a Photosensitising Agent in 2D and 3D Models

Unraveling Microviscosity Changes Induced in Cancer Cells by Photodynamic Therapy with Targeted Genetically Encoded Photosensitizer

<title>High-sensitivity imaging method of singlet oxygen and superoxide anion in photodynamic and sonodynamic actions</title>

External stimuli-triggered photodynamic and sonodynamic therapies in combination with hybrid nanomicelles of ICG@PEP@HA: laser vs. ultrasound

Synthesis, Charatcterization and Preclinical Studies of Tartgeted Photo-Dynamic Therapy Agents Activated in the Tissue Transparency Window

Quantitative assessment of changes in cellular morphology at photodynamic treatment in vitro by means of digital holographic microscopy

Modulation of heat shock protein expression and cytokine levels in MCF-7 cells through photodynamic therapy

Distribution and photobleaching of photosensitizer chlorophyll derivative (CPD) in SMCF7 cancer cells

Assessment of Photosensitizer Concentration Effects on the Efficacy of Photodynamic Therapy

Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer

In Vivo Measurement of Parameters of Dosimetric Importance During Interstitial Photodynamic Therapy of Thick Skin Tumors

Effects of Photodynamic Therapy on Tumor Metabolism and Oxygenation Revealed by Fluorescence and Phosphorescence Lifetime Imaging

High-sensitive imaging method of singlet oxygen and Superoxide anion in photodynamic and sonodynamic actions

Effects of Zinc Phthalocyanine Photodynamic Therapy on Vital Structures and Processes in Hela Cells

Evaluation of oxidative damage to biologic molecule by monitoring chemiluminescence during the course of photosensitization

System for Integrated Interstitial Photodynamic Therapy and Dosimetric Monitoring

Effect of Sono-photodynamic Combination Therapy on the Ultrastructure of Squamous Cell Carcinoma in Mice

Photodynamic Therapy Dosimetry Using Multiexcitation Multiemission Wavelength: Toward Real-Time Prediction of Treatment Outcome

Application of a Dual-Probe Coloading Nanodetection System in the Process Monitoring and Efficacy Assessment of Photodynamic Therapy: An <i>In Vitro</i> Study